Your browser doesn't support javascript.
loading
Neuroimaging, clinical and life course correlates of normal-appearing white matter integrity in 70-year-olds.
James, Sarah-Naomi; Manning, Emily N; Storey, Mathew; Nicholas, Jennifer M; Coath, William; Keuss, Sarah E; Cash, David M; Lane, Christopher A; Parker, Thomas; Keshavan, Ashvini; Buchanan, Sarah M; Wagen, Aaron; Harris, Mathew; Malone, Ian; Lu, Kirsty; Needham, Louisa P; Street, Rebecca; Thomas, David; Dickson, John; Murray-Smith, Heidi; Wong, Andrew; Freiberger, Tamar; Crutch, Sebastian J; Fox, Nick C; Richards, Marcus; Barkhof, Frederik; Sudre, Carole H; Barnes, Josephine; Schott, Jonathan M.
  • James SN; MRC Unit for Lifelong Health and Ageing at UCL, Institute of Cardiovascular Science, University College London, London, UK.
  • Manning EN; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Storey M; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Nicholas JM; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Coath W; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Keuss SE; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
  • Cash DM; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Lane CA; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Parker T; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Keshavan A; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Buchanan SM; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Wagen A; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Harris M; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Malone I; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Lu K; Centre for Medical Image Computing, University College London, London, UK.
  • Needham LP; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Street R; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Thomas D; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Dickson J; MRC Unit for Lifelong Health and Ageing at UCL, Institute of Cardiovascular Science, University College London, London, UK.
  • Murray-Smith H; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Wong A; Neuroradiological Academic Unit, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, London, UK.
  • Freiberger T; Institute of Nuclear Medicine, University College London Hospitals Foundation Trust, London, UK.
  • Crutch SJ; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Fox NC; MRC Unit for Lifelong Health and Ageing at UCL, Institute of Cardiovascular Science, University College London, London, UK.
  • Richards M; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Barkhof F; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Sudre CH; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Barnes J; MRC Unit for Lifelong Health and Ageing at UCL, Institute of Cardiovascular Science, University College London, London, UK.
  • Schott JM; Centre for Medical Image Computing, University College London, London, UK.
Brain Commun ; 5(5): fcad225, 2023.
Article en En | MEDLINE | ID: mdl-37680671
We investigate associations between normal-appearing white matter microstructural integrity in cognitively normal ∼70-year-olds and concurrently measured brain health and cognition, demographics, genetics and life course cardiovascular health. Participants born in the same week in March 1946 (British 1946 birth cohort) underwent PET-MRI around age 70. Mean standardized normal-appearing white matter integrity metrics (fractional anisotropy, mean diffusivity, neurite density index and orientation dispersion index) were derived from diffusion MRI. Linear regression was used to test associations between normal-appearing white matter metrics and (i) concurrent measures, including whole brain volume, white matter hyperintensity volume, PET amyloid and cognition; (ii) the influence of demographic and genetic predictors, including sex, childhood cognition, education, socio-economic position and genetic risk for Alzheimer's disease (APOE-ɛ4); (iii) systolic and diastolic blood pressure and cardiovascular health (Framingham Heart Study Cardiovascular Risk Score) across adulthood. Sex interactions were tested. Statistical significance included false discovery rate correction (5%). Three hundred and sixty-two participants met inclusion criteria (mean age 70, 49% female). Higher white matter hyperintensity volume was associated with lower fractional anisotropy [b = -0.09 (95% confidence interval: -0.11, -0.06), P < 0.01], neurite density index [b = -0.17 (-0.22, -0.12), P < 0.01] and higher mean diffusivity [b = 0.14 (-0.10, -0.17), P < 0.01]; amyloid (in men) was associated with lower fractional anisotropy [b = -0.04 (-0.08, -0.01), P = 0.03)] and higher mean diffusivity [b = 0.06 (0.01, 0.11), P = 0.02]. Framingham Heart Study Cardiovascular Risk Score in later-life (age 69) was associated with normal-appearing white matter {lower fractional anisotropy [b = -0.06 (-0.09, -0.02) P < 0.01], neurite density index [b = -0.10 (-0.17, -0.03), P < 0.01] and higher mean diffusivity [b = 0.09 (0.04, 0.14), P < 0.01]}. Significant sex interactions (P < 0.05) emerged for midlife cardiovascular health (age 53) and normal-appearing white matter at 70: marginal effect plots demonstrated, in women only, normal-appearing white matter was associated with higher midlife Framingham Heart Study Cardiovascular Risk Score (lower fractional anisotropy and neurite density index), midlife systolic (lower fractional anisotropy, neurite density index and higher mean diffusivity) and diastolic (lower fractional anisotropy and neurite density index) blood pressure and greater blood pressure change between 43 and 53 years (lower fractional anisotropy and neurite density index), independently of white matter hyperintensity volume. In summary, poorer normal-appearing white matter microstructural integrity in ∼70-year-olds was associated with measures of cerebral small vessel disease, amyloid (in males) and later-life cardiovascular health, demonstrating how normal-appearing white matter can provide additional information to overt white matter disease. Our findings further show that greater 'midlife' cardiovascular risk and higher blood pressure were associated with poorer normal-appearing white matter microstructural integrity in females only, suggesting that women's brains may be more susceptible to the effects of midlife blood pressure and cardiovascular health.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article